Liberty Mutual Group Asset Management Inc. boosted its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 1.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,529 shares of the company’s stock after buying an additional 206 shares during the period. Liberty Mutual Group Asset Management Inc.’s holdings in LivaNova PLC were worth $957,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in LIVN. Meadow Creek Investment Management LLC boosted its position in shares of LivaNova PLC by 11.4% in the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after buying an additional 252 shares during the period. Glen Harbor Capital Management LLC boosted its position in shares of LivaNova PLC by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock worth $147,000 after buying an additional 306 shares during the period. Capstone Asset Management Co. purchased a new position in shares of LivaNova PLC during the first quarter worth about $233,000. Advantus Capital Management Inc boosted its position in shares of LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock worth $272,000 after buying an additional 176 shares during the period. Finally, OppenheimerFunds Inc. purchased a new position in shares of LivaNova PLC during the first quarter worth about $291,000. 72.76% of the stock is currently owned by hedge funds and other institutional investors.
LivaNova PLC (NASDAQ LIVN) traded down 0.99% during trading on Friday, reaching $60.99. 269,848 shares of the company traded hands. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $63.21. The firm’s 50 day moving average price is $60.89 and its 200 day moving average price is $53.49. The firm’s market capitalization is $2.98 billion.
LivaNova PLC (NASDAQ:LIVN) last issued its quarterly earnings data on Wednesday, May 3rd. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. LivaNova PLC had a negative net margin of 0.92% and a positive return on equity of 8.77%. The business had revenue of $285.10 million during the quarter. Equities research analysts expect that LivaNova PLC will post $3.11 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This news story was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/07/22/liberty-mutual-group-asset-management-inc-buys-206-shares-of-livanova-plc-livn-updated-updated-updated.html.
In other LivaNova PLC news, Director Hugh M. Morrison sold 3,215 shares of the business’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $55.89, for a total value of $179,686.35. Following the transaction, the director now directly owns 2,000 shares in the company, valued at $111,780. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Alfred J. Novak sold 1,000 shares of the business’s stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $58.49, for a total transaction of $58,490.00. Following the completion of the transaction, the director now owns 12,020 shares in the company, valued at $703,049.80. The disclosure for this sale can be found here. Insiders sold a total of 6,215 shares of company stock valued at $360,526 over the last ninety days. 0.28% of the stock is currently owned by insiders.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.